Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,107 public trials 145 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)

NCT06122831

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangxi Zhuang Autonomous Region People's Hospital Nanning, Guangxi, China
  • Cangzhou People's Hosipital Cangzhou, Hebei, China
  • Affiliated Hospital of Chengde Medical College Chengde, Hebei, China
View all 22 locations
View Trial Details
Recruiting

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

NCT06552429

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Peking Union Hospital, Chinese Academy of Medical Sciences Beijing, China
  • Peking University People's Hospital Beijing, China
  • Union Hospital affiliated to Fujian Medical University Fujian, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View Trial Details
Recruiting

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04260022

Conditions
B Cell Precursor Type Acute Leukemia, Blast Crisis, Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Augusta Cancer Center Augusta, Georgia, United States
View Trial Details
Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

NCT03595917

Conditions
B-cell Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Burkitt Lymphoma, +27 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis

NCT06397313

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Policlinico Sant'Orsola-Malpighi Bologna, Italy
  • Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
  • Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco" Catania, Italy
  • Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. Meldola, Italy
View all 18 locations
View Trial Details

Related conditions